Feedback / Questions
berubicin (RTA 744) - CNS Pharma, WPD Pharma
https://www.prnewswire.com/news-releases/cns-pharmaceuticals-engages-berry-consultants-to-advise-phase-2-trial-design-301085581.html
Jun 30, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next